Search

everythinglearnresearchcommunity

for

Search:↓

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Check and treat low iron and vitamin D levels in people with hair loss.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

Growth Factor Concentrate is more effective than Platelet-Rich Plasma for improving hair density and thickness.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

64 drugs can cause hair loss, needing better monitoring and updated labels.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.

Homeopathic treatment helped a girl regrow hair after other treatments failed.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

People with alopecia have a higher risk of thyroid cancer.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

A boy's hair, nails, and skin improved after 6 months of steroid treatment.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

COVID-19 infection may trigger alopecia areata in some patients.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

PRP improves hair thickness for both genders, but only increases hair density in men.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

A patient with a rare hair condition and skin disorder showed hair improvement after treatment.

Exosomes helped regrow hair in a 14-year-old with difficult-to-treat alopecia.